PCM
VYNT

Perkins Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Perkins Capital Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-233
Closed -$4K – 119
2019
Q3 		$4K Sell
233
-19,659
-99% -$383K ﹤0.01% 112
2019
Q2 		$487K Sell
19,892
-1,018
-5% -$31.8K 0.34% 81
2019
Q1 		$753K Buy
20,910
+18,122
+650% +$745K 0.5% 63
2018
Q4 		$101K Sell
2,788
-5,794
-68% -$488K 0.08% 115
2018
Q3 		$1.34M Buy
8,582
+1,885
+28% +$279K 0.8% 42
2018
Q2 		$894K Buy
6,697
+273
+4% +$41.3K 0.64% 53
2018
Q1 		$1.59M Sell
6,424
-174
-3% -$49K 1.43% 14
2017
Q4 		$1.83M Buy
6,598
+1,220
+23% +$465K 1.76% 10
2017
Q3 		$2.18M Sell
5,378
-144
-3% -$75.1K 2.28% 7
2017
Q2 		$3.27M Sell
5,522
-57
-1% -$33.3K 3.63% 5
2017
Q1 		$3.43M Sell
5,579
-178
-3% -$63.3K 3.54% 5
2016
Q4 		$1.17M Sell
5,757
-7
-0.1% -$1.59K 1.28% 22
2016
Q3 		$1.51M Buy
5,764
+1,889
+49% +$579K 1.51% 17
2016
Q2 		$1.16M Buy
3,875
+2,642
+214% +$929K 1.33% 23
2016
Q1 		$525K Hold
1,233
– – 0.66% 54
2015
Q4 		$610K Buy
+1,233
New +$891K 0.65% 53
2014
Q2 		– Sell
-514
Closed -$1.16M – 146
2014
Q1 		$1.16M Sell
514
-31
-6% -$79.4K 0.82% 46
2013
Q4 		$1.13M Buy
+545
New +$1.18M 0.76% 48

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Perkins Capital Management's VYNT Position: Q4 2019 in Review

Perkins Capital Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2019, closing a stake of 233 shares — an estimated $4K sold.

Perkins Capital Management first reported a position in VYNT in Q4 2013 and held it in 18 quarters. The position peaked at $3.43M in Q1 2017. 18 funds tracked by Wall St. Rank hold VYNT as of Q4 2019.

  • Perkins Capital Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Perkins Capital Management sold 233 Vyant Bio, Inc. Common Stock shares in Q4 2019, an estimated $4K.
  • Perkins Capital Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 18 quarters.
  • Perkins Capital Management's Vyant Bio, Inc. Common Stock position peaked at $3.43M in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2019.

Based on Perkins Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.